Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Fresenius SE & Co. KGaA
  6. News
  7. Summary
    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
Delayed Xetra  -  05/20 11:35:26 am EDT
32.31 EUR   +1.64%
05/20FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons
EQ
05/19FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons
EQ
05/16FRESENIUS SE & CO. KGAA : Ex-dividend day for final dividend
FA
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Transcript : Fresenius SE & Co. KGaA - Shareholder/Analyst Call

05/13/2022 | 04:00am EDT
share with twitter
share with LinkedIn
share with facebook
Good morning, ladies and gentlemen. My name is Wolfgang Kirsch. As the Chairman of the Supervisory Board, I would like to open the AGM 2022 of Fresenius SE & Co. KGaA. And I will take the...


© S&P Capital IQ 2022
All news about FRESENIUS SE & CO. KGAA
05/20FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons
EQ
05/19FRESENIUS SE & CO. KGAA : Notification and public disclosure of transactions by persons
EQ
05/16FRESENIUS SE & CO. KGAA : Ex-dividend day for final dividend
FA
05/16FRESENIUS SE & CO. KGAA : Ex-dividend day for final dividend (optional)
FA
05/13TRANSCRIPT : Fresenius SE & Co. KGaA - Shareholder/Analyst Call
CI
05/13FRESENIUS SE : JP Morgan reiterates its Neutral rating
MD
05/12FRESENIUS SE : DZ Bank reaffirms its Buy rating
MD
05/10FRESENIUS SE : Buy rating from Warburg Research
MD
05/06Fresenius SE & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, ..
CI
05/06FRESENIUS SE : Credit Suisse remains Neutral
MD
More news
Analyst Recommendations on FRESENIUS SE & CO. KGAA
More recommendations
Financials
Sales 2022 40 073 M 42 276 M 42 276 M
Net income 2022 1 841 M 1 942 M 1 942 M
Net Debt 2022 22 016 M 23 226 M 23 226 M
P/E ratio 2022 9,75x
Yield 2022 3,00%
Capitalization 18 045 M 19 037 M 19 037 M
EV / Sales 2022 1,00x
EV / Sales 2023 0,92x
Nbr of Employees 317 242
Free-Float 73,4%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 32,31 €
Average target price 44,16 €
Spread / Average Target 36,7%
EPS Revisions
Managers and Directors
Stephan Sturm Chairman-Management Board & CEO
Rachel Clare Empey Chief Financial Officer
Wolfgang Kirsch Chairman-Supervisory Board
Michael Albrecht Independent Member-Supervisory Board
Konrad Kölbl Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
FRESENIUS SE & CO. KGAA-8.73%19 037
AIER EYE HOSPITAL GROUP CO., LTD.-16.93%28 449
IHH HEALTHCARE BERHAD-11.04%13 097
RAMSAY HEALTH CARE LIMITED10.21%12 613
BANGKOK DUSIT MEDICAL SERVICES PUBLIC COMPANY LIMITED17.39%12 466
APOLLO HOSPITALS ENTERPRISE LIMITED-26.84%6 778